Differential (Click to cross reference) adverse drug reaction atorvastatin cerivastatin Clinical Pathologic Conference(C.P.C.) creatine phosphokinase(CPK)elevated diabetes mellitus drug induced neurologic disorders drug interactions electromyogram fibrate fibrillations gemfibrozil HMGcoA reductase inhibitors human diploid cell rabies vaccine hyporeflexia iatrogenic neurologic disorders leg weakness, bilateral lipid lowering agent lovastatin muscle biopsy muscle cramp muscle pain muscle tenderness muscle weakness myasthenia gravis myasthenia gravis, exacerbation myopathy myopathy, drug-induced myopathy, necrotizing myopathy, toxic myotonic discharges neck weakness neoplasm, primary of CNS-intraventricular old age, neurology of pain, leg paresthesias prognosis renal failure rhabdomyolysis simvastatin statin therapy walking, difficulty with weakness weakness, generalized weakness, progressive

Showing articles 0 to 6 of 6 Clinicopathologic Conference,Necrotizing Noninflammatory Myopathy Consistent with Exposure to Statins NEJM 36:944-954, Case 7-2012, 2012 Incidence of Hospitalized Rhabdomyloysis in Patients Treated With Lipid-Lowering Drugs JAMA 292:2585-2590, Graham,D.J.,et al, 2004 Statin-Associated Exacerbation of Myasthenia Gravis Neurol 63:2188, Cartwright,M.S.,et al, 2004 Gemfibrozil-Induced Myopathy Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991 Cholesterol-Lowering Agent Myopathy (CLAM) Neurol 41:1159-1160, London,S.F.,et al, 1991 Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy JAMA 264:71-75, Pierce,L.R.,et al, 1990 Showing articles 0 to 6 of 6